The Stroma—A Key Regulator in Prostate Function and Malignancy
AbstractProstate cancer is a very common and highly unpredictable form of cancer. Whereas many prostate cancers are slow growing and could be left without treatment, others are very aggressive. Additionally, today there is no curative treatment for prostate cancer patients with local or distant metastasis. Identification of new, improved prognostic and diagnostic biomarkers for prostate cancer and the finding of better treatment strategies for metastatic prostate cancer is therefore highly warranted. Interactions between epithelium and stroma are known to be important already during prostate development and this interplay is critical also in development, progression of primary tumors and growth of metastases. It is therefore reasonable to expect that future biomarkers and therapeutic targets can be identified in the prostate tumor and metastasis stroma and this possibility should be further explored. View Full-Text
Scifeed alert for new publicationsNever miss any articles matching your research from any publisher
- Get alerts for new papers matching your research
- Find out the new papers from selected authors
- Updated daily for 49'000+ journals and 6000+ publishers
- Define your Scifeed now
Hägglöf, C.; Bergh, A. The Stroma—A Key Regulator in Prostate Function and Malignancy. Cancers 2012, 4, 531-548.
Hägglöf C, Bergh A. The Stroma—A Key Regulator in Prostate Function and Malignancy. Cancers. 2012; 4(2):531-548.Chicago/Turabian Style
Hägglöf, Christina; Bergh, Anders. 2012. "The Stroma—A Key Regulator in Prostate Function and Malignancy." Cancers 4, no. 2: 531-548.